Key clinical point: Adjunctive CBD reduces the rate of convulsive seizures in patients with Dravet syndrome.
Major finding: The 10-mg/kg per day dose reduced the rate of convulsive seizures by 49%.
Study details: A prospective, randomized, placebo-controlled study of 199 children with Dravet syndrome.
Disclosures: GW Research supported the study. Dr. Miller has received compensation and research support from several companies, including GW Pharma.
Miller I et al. AAN 2019, Abstract P3.6-076.